Director and significant shareholder of MACOM Technology Solutions Holdings, Inc., Susan Ocampo, recently sold shares valued at around $32.3 million. The sales, conducted on November 22, 25, and 26, involved multiple batches of common stock at prices ranging from $133.15 to $137.18 per share. Ocampo now holds 6,313,193 shares indirectly through the Ocampo Family Trust and additional shares for her children.
In other news, MACOM received positive analyst attention, with Needham & Company upgrading its stock price target to $150 from $120 and maintaining a Buy rating. This adjustment followed the company’s strong financial results, including the fourth fiscal quarter of 2024 where they reported a record quarterly revenue of $200.7 million.
Looking ahead, MACOM aims to surpass an annual revenue run rate of $1 billion by fiscal year 2026. Despite potential industry headwinds, including cyclical volatility, the company anticipates growth driven by new optical technologies. Needham forecasts these technologies becoming significant revenue contributors as early as fiscal year 2025.
InvestingPro Insights report that MTSI’s stock performance has been strong, with a 59.02% total return over the past year and a 28.81% return in the last three months. The stock is currently trading at 95.98% of its 52-week high, showing robust investor confidence. Analysts also predict net income growth for the company this year.
While insider selling activity by Ocampo has occurred, MACOM’s financial health appears solid, with strong revenue growth and manageable debt levels. However, the company’s high valuation multiples indicate potential risks that investors should carefully consider. For a more in-depth analysis, InvestingPro offers additional tips on MTSI’s financial health and market position.
Source
Photo credit www.investing.com